PCT testing has been suggested in critical patients because raised serum biomarker concentrations may reveal a superimposed bacterial co-infection, which, in turn, supplements disease severity and possibly drives systemic sepsis, also allowing a more targeted use of antimicrobials and promoting antibiotic stewardship even in COVID-19 [37]. This evidence concerns the gene CALCA and COVID-19.